Insufficient scRNA-seq data for expression of EID2B at single-cell level.
Insufficient scRNA-seq data for expression of EID2B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 696.56 | 2636 / 2642 | 100% | 11.95 | 705 / 705 |
| thymus | 100% | 239.01 | 651 / 653 | 100% | 7.98 | 605 / 605 |
| adrenal gland | 100% | 206.93 | 257 / 258 | 100% | 10.45 | 229 / 230 |
| prostate | 99% | 227.48 | 243 / 245 | 98% | 3.66 | 494 / 502 |
| breast | 98% | 154.94 | 450 / 459 | 95% | 3.08 | 1061 / 1118 |
| kidney | 96% | 153.61 | 85 / 89 | 97% | 4.51 | 874 / 901 |
| ovary | 100% | 320.73 | 180 / 180 | 90% | 2.93 | 385 / 430 |
| uterus | 99% | 322.33 | 168 / 170 | 90% | 4.00 | 415 / 459 |
| lung | 96% | 165.44 | 557 / 578 | 87% | 2.60 | 1008 / 1155 |
| bladder | 100% | 216.05 | 21 / 21 | 67% | 1.94 | 338 / 504 |
| skin | 62% | 84.05 | 1126 / 1809 | 99% | 5.07 | 468 / 472 |
| esophagus | 75% | 174.34 | 1078 / 1445 | 62% | 1.23 | 114 / 183 |
| intestine | 90% | 204.39 | 870 / 966 | 43% | 0.84 | 229 / 527 |
| pancreas | 34% | 29.24 | 113 / 328 | 96% | 3.98 | 170 / 178 |
| stomach | 70% | 105.94 | 250 / 359 | 49% | 0.90 | 141 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 5.26 | 29 / 29 |
| spleen | 100% | 241.06 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.37 | 1 / 1 |
| blood vessel | 99% | 241.48 | 1327 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 94% | 145.96 | 1134 / 1204 | 0% | 0 | 0 / 0 |
| heart | 90% | 129.02 | 776 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 78% | 1.93 | 35 / 45 |
| liver | 18% | 14.54 | 40 / 226 | 57% | 1.31 | 233 / 406 |
| eye | 0% | 0 | 0 / 0 | 75% | 1.92 | 60 / 80 |
| muscle | 69% | 73.37 | 554 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 34% | 63.32 | 315 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030154 | Biological process | cell differentiation |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0007517 | Biological process | muscle organ development |
| GO_0045662 | Biological process | negative regulation of myoblast differentiation |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0003714 | Molecular function | transcription corepressor activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | EID2B |
| Protein name | EP300-interacting inhibitor of differentiation 2B (EID-2B) (EID-2-like inhibitor of differentiation 3) (EID-3) |
| Synonyms | EID3 |
| Description | FUNCTION: Acts as a repressor of MYOD-dependent transcription, glucocorticoid receptor-dependent transcription, and muscle differentiation. . |
| Accessions | ENST00000326282.5 Q96D98 |